参考文献/References:
[1] Bai J, Wang F, Wang X, et al. Expression and clinical significance of HSP27 and its phosphorylation in lower extremity arteriosclerosis obliterans[J]. PeerJ, 2020, 8: e9305.
[2] Ren HC, Zhuang JM, Li X, et al. Avoiding revascularization strategy versus revascularization with drug- coated balloon for the treatment of superficial femoral artery occlusive disease[J]. J Intervent Med, 2021, 4: 87- 93.
[3] Kim MS, Dean LS. In- stent restenosis[J]. Cardiovasc Ther, 2011, 29: 190- 198.
[4] Kokkinidis DG, Waldo SW, Armstrong EJ. Treatment of coronary artery in- stent restenosis[J]. Expert Rev Cardiovasc Ther, 2017, 15: 191- 202.
[5] Liu H, Mao Z, Zhu J, et al. MiR- 140- 5p inhibits oxidized low- density lipoprotein- induced oxidative stress and cell apoptosis via targeting toll- like receptor 4[J]. Gene Ther, 2021, 28: 413- 421.
[6] 中华医学会外科学分会血管外科学组. 下肢动脉硬化闭塞症诊治指南[J]. 中华医学杂志, 2015, 95:1883- 1896.
[7] Wang Y, Shen S, Li Z, et al. MIR- 140- 5p affects chondrocyte proliferation, apoptosis, and inflammation by targeting HMGB1 in osteoarthritis[J]. Inflamm Res, 2020, 69: 63- 73.
[8] 杜自忠,王 晨,张明星,等. 下肢动脉硬化闭塞症患者介入治疗后血清miR- 342- 5p水平及其意义[J]. 介入放射学杂志, 2020, 29:894- 898.
[9] Wang K, Yu J, Wang B, et al. miR- 29a regulates the proliferation and migration of human arterial smooth muscle cells in arteriosclerosis obliterans of the lower extremities[J]. Kidney Blood Press Res, 2019, 44: 1219- 1232.
[10] Yu ZH, Wang HT, Tu C. Diagnostic value of microRNA- 143 in predicting in- stent restenosis for patients with lower extremity arterial occlusive disease[J]. Eur J Med Res, 2017, 22: 2.
[11] 徐永平,陈伟彬,陈俊卯,等.下肢动脉硬化闭塞症患者外周血单个核细胞中CBX3水平与介入术后1年内支架内再狭窄的关系[J]. 山西医科大学学报, 2020, 51:999- 1004.
[12] Wang Z, Hu J, Pan Y, et al. miR- 140- 5p/miR- 149 affects chondrocyte proliferation, apoptosis, and autophagy by targeting FUT1 in osteoarthritis[J]. Inflammation, 2018, 41: 959- 971.
[13] Wang S, Cui Y, Xu J, et al. miR- 140- 5p attenuates neuroinfla-mmation and brain injury in rats following intracerebral hemorrhage by targeting TLR4[J]. Inflammation, 2019, 42: 1869- 1877.
[14] 陈 懿,陆舜钦. 下肢动脉粥样硬化闭塞症患者C型凝集素样受体- 2水平与介入术后2年支架内再狭窄的关系[J]. 介入放射学杂志, 2021, 30:498- 501.
[15] 曾仲衍,李嘉宏,黄敏捷,等.下肢动脉硬化闭塞经介入治疗后再狭窄的危险因素分析[J]. 福建医药杂志, 2020, 42:51- 55.
[16] 周欣峰,戚韶红,周俊文,等. 血清sTREM- 1对下肢动脉硬化闭塞症支架植入术后血管再狭窄的预测价值[J].山东医药,2020, 60:18- 22.
相似文献/References:
[1]陈国平,顾建平,楼文胜,等.股深动脉血流重建改善下肢缺血的临床应用[J].介入放射学杂志,2011,(10):782.
CHEN Guo-ping,GU Jian-ping,LOU Wen-sheng,et al.The clinical application of reconstitution of deep femoral arterial blood flow in improving the ischemic symptoms of lower extremities[J].journal interventional radiology,2011,(06):782.
[2]刘 洪,王学虎,李凤贺,等.导管接触溶栓在下肢动脉硬化闭塞慢性缺血治疗中的应用[J].介入放射学杂志,2019,28(11):1032.
LIU Hong,WANG Xuehu,LI Fenghe,et al.Application of catheter- directed thrombolysis in the treatment of lower extremity arteriosclerosis obliterans with chronic ischemia[J].journal interventional radiology,2019,28(06):1032.
[3]韩亚庆,丁宁宁,周 丽,等.CTA与DSA评估慢性肢体威胁性缺血患者全球肢体解剖学分期系统分期的一致性分析[J].介入放射学杂志,2024,33(03):300.
HAN Yaqing,DING Ningning,ZHOU Li,et al.Analysis of the consistency between CTA and DSA in evaluating GLASS staging of chronic limb-threatening ischemia[J].journal interventional radiology,2024,33(06):300.